The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
Brainstorm Cell Therapeutics, Inc (NASDAQ: BCLI) closed the day trading at $1.08 down -2.70% from the previous closing price of $1.11. In other words, the price has decreased by -$2.70 from its previous closing price. On the day, 0.33 million shares were traded. BCLI stock price reached its highest trading level at $1.1199 during the session, while it also had its lowest trading level at $1.05.
Ratios:
For a better understanding of BCLI, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.21 and its Current Ratio is at 0.21.
Maxim Group reiterated its Buy rating for the stock on December 19, 2016, while the target price for the stock was revised from $5 to $6.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Oct 01 ’24 when Lebovits Chaim bought 1,836 shares for $3.43 per share. The transaction valued at 6,292 led to the insider holds 80,960 shares of the business.
Lebovits Chaim bought 22,000 shares of BCLI for $5,016 on Sep 30 ’24. The President & CEO now owns 1,186,865 shares after completing the transaction at $0.23 per share. On Jul 19 ’24, another insider, Dagher Ibrahim B., who serves as the Chief Medical Officer of the company, sold 63,000 shares for $0.35 each. As a result, the insider received 22,069 and left with 0 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BCLI now has a Market Capitalization of 8573991 and an Enterprise Value of 8670100.
Stock Price History:
The Beta on a monthly basis for BCLI is 0.25, which has changed by -0.86153847 over the last 52 weeks, in comparison to a change of 0.09362543 over the same period for the S&P500. Over the past 52 weeks, BCLI has reached a high of $9.45, while it has fallen to a 52-week low of $0.72. The 50-Day Moving Average of the stock is -8.13%, while the 200-Day Moving Average is calculated to be -49.67%.
Shares Statistics:
Over the past 3-months, BCLI traded about 1.17M shares per day on average, while over the past 10 days, BCLI traded about 6381400 shares per day. A total of 7.91M shares are outstanding, with a floating share count of 6.17M. Insiders hold about 22.32% of the company’s shares, while institutions hold 12.88% stake in the company. Shares short for BCLI as of 1745971200 were 291418 with a Short Ratio of 0.25, compared to 1743379200 on 137216. Therefore, it implies a Short% of Shares Outstanding of 291418 and a Short% of Float of 5.06.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
